case_images: PMC7338642_01
case_images: PMC7338642_02
case_images: PMC7338642_03
case_images: Clinical manifestations of the case. *Plasma derived; **recombinant;  immune tolerance induction.
case_images: 10.1177_2058738420934618-fig1.jpg
case_images: PMC7338642_03_10.1177_2058738420934618-fig1.jpg
case_images: fig1-2058738420934618
case_images: He finally used non-factor replacement (emicizumab) without inhibitor recurrence (Figure 1).